ArticleParkinson's disease2023

A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson's Disease.

Zijuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.